Characterization of [11C]tetrabenazine as an in vivo radioligand for the vesicular monoamine transporter
- 1 February 1994
- journal article
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 21 (2) , 151-156
- https://doi.org/10.1016/0969-8051(94)90003-5
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- In vivo imaging of monoaminergic nerve terminals in normal and MPTP‐lesioned primate brain using positron emission tomography (PET) and [11C]tetrabenazineSynapse, 1993
- In Vivo Imaging of Vesicular Monoamine Transporters in Human Brain Using [11C]Tetrabenazine and Positron Emission TomographyJournal of Neurochemistry, 1993
- Synthesis of [11C]tetrabenazine, a vesicular monoamine uptake inhibitor, for PET imaging studiesApplied Radiation and Isotopes, 1993
- Striatal binding of the PET ligand 11C‐raclopride is altered by drugs that modify synaptic dopamine levelsSynapse, 1993
- A cDNA that suppresses MPP+ toxicity encodes a vesicular amine transporterCell, 1992
- In vivo binding of [11C]tetrabenazine to vesicular monoamine transporters in mouse brainLife Sciences, 1992
- [3H]Dihydrotetrabenazine, a new marker for the visualization of dopaminergic denervation in the rat striatumNeuroscience Letters, 1990
- Radioligands of the vesicular monoamine transporter and their use as markers of monoamine storage vesiclesBiochemical Pharmacology, 1989
- Direct Injection High-Performance Liquid Chromatography of Tetrabenazine and Its Metabolite in Plasma of Humans and RatsJournal of Pharmaceutical Sciences, 1986
- Tetrabenazine has properties of a dopamine receptor antagonistAnnals of Neurology, 1982